Terms: = Ovarian cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
17 results:
1. Anlotinib Inhibits ovarian cancer and Enhances Cisplatinum Sensitivity
Xu X; Wang Q; Shen L; Shen Y; Liu H; Liu Y; Yang Z; Hoffman RM; Feng W
Anticancer Res; 2024 Apr; 44(4):1399-1407. PubMed ID: 38538004
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
4. Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.
Yang J; Xing H; Lu D; Wang J; Li B; Tang J; Gu F; Hong L
J Cell Mol Med; 2019 Jun; 23(6):4005-4018. PubMed ID: 30993885
[TBL] [Abstract] [Full Text] [Related]
5. Dendrimer-paclitaxel complexes for efficient treatment in ovarian cancer: study on OVCAR-3 and HEK293T cells.
Yao H; Ma J
Acta Biochim Pol; 2018; 65(2):219-225. PubMed ID: 29913480
[TBL] [Abstract] [Full Text] [Related]
6. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating notch2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract] [Full Text] [Related]
8. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
Zhou X; Teng L; Wang M
Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
[TBL] [Abstract] [Full Text] [Related]
9. Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin.
Adam-Zahir S; Plowman PN; Bourton EC; Sharif F; Parris CN
Chemotherapy; 2014; 60(5-6):310-20. PubMed ID: 26138778
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Notch signaling with a notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract] [Full Text] [Related]
11. ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature.
Roy L; Samyesudhas SJ; Carrasco M; Li J; Joseph S; Dahl R; Cowden Dahl KD
Oncotarget; 2014 Sep; 5(18):8355-66. PubMed ID: 25327563
[TBL] [Abstract] [Full Text] [Related]
12. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.
Egloff AM; Grandis JR
Clin Cancer Res; 2012 Oct; 18(19):5188-95. PubMed ID: 22773520
[TBL] [Abstract] [Full Text] [Related]
13. cancer stem cells as targets for cancer therapy: selected cancers as examples.
Hombach-Klonisch S; Paranjothy T; Wiechec E; Pocar P; Mustafa T; Seifert A; Zahl C; Gerlach KL; Biermann K; Steger K; Hoang-Vu C; Schulze-Osthoff K; Los M
Arch Immunol Ther Exp (Warsz); 2008; 56(3):165-80. PubMed ID: 18512024
[TBL] [Abstract] [Full Text] [Related]
14. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.
Clingen PH; Wu JY; Miller J; Mistry N; Chin F; Wynne P; Prise KM; Hartley JA
Biochem Pharmacol; 2008 Jul; 76(1):19-27. PubMed ID: 18508035
[TBL] [Abstract] [Full Text] [Related]
15. PET-CT vs. CT alone in ovarian cancer recurrence.
Sebastian S; Lee SI; Horowitz NS; Scott JA; Fischman AJ; Simeone JF; Fuller AF; Hahn PF
Abdom Imaging; 2008; 33(1):112-8. PubMed ID: 17404789
[TBL] [Abstract] [Full Text] [Related]
16. Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.
Ishiyama S; Matsueda S; Jones LA; Efferson C; Celestino J; Schmandt R; Ioannides CG; Tsuda N; Chang DZ
Int J Oncol; 2007 Apr; 30(4):889-98. PubMed ID: 17332928
[TBL] [Abstract] [Full Text] [Related]
17. Decreased stability of DNA in cells treated with alkylating agents.
Frankfurt OS
Exp Cell Res; 1990 Dec; 191(2):181-5. PubMed ID: 2257876
[TBL] [Abstract] [Full Text] [Related]
